Internal Medicine · Portland, OR
NPI
1063767317
Since 2012
Specialty
Internal Medicine
Code 207R00000X
Group practices
8
Medicare group memberships
Hospitals
3
Hospital affiliations
9135 SW Barnes Rd Ste 261
Portland, OR, 97225
Phone (503) 216-6300
Groups this clinician bills Medicare through
Medicare paid, 2024
$64K
977 services
Medicare patients, 2024
187
Average age 74
Drug cost, 2024
$2.3M
833 prescriptions
Company payments, 2025
$1,414
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Natasha C Edwin was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 323 times for 132 patients. In total Natasha C Edwin billed 977 services in 18 codes, and Medicare paid $64K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-04-26.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 323 | 132 | $12.67 | $4,094 |
| 99214 Office E&M - Established | Office | 212 | 109 | $96.36 | $20K |
| 99233 Hospital E&M - Subsequent | Facility | 92 | 30 | $93.34 | $8,587 |
| 99215 Office E&M - Established | Office | 72 | 41 | $141.32 | $10K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 64 | 19 | $12.08 | $773 |
| 99214 Office E&M - Established | Facility | 49 | 15 | $68.03 | $3,334 |
| 99205 Office E&M - New | Office | 36 | 36 | $167.93 | $6,045 |
| 36415 Venipuncture Blood Collection | Facility | 27 | 23 | $8.65 | $234 |
| 99204 Office E&M - New | Office | 20 | 20 | $119.30 | $2,386 |
| 99223 Hospital E&M - Initial | Facility | 19 | 18 | $136.09 | $2,586 |
| G0452 Molecular pathology procedure; physician interpretation and report | Facility | 13 | 13 | $37.03 | $481 |
By year: 2022 $44K for 423 services; 2023 $55K for 560 services; 2024 $64K for 977 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 27 | 23 | $8.65 | $234 |
| G0452 Molecular pathology procedure; physician interpretation and report | 13 | 13 | $37.03 | $481 |
Medicare prescription drug claims, 2024
In 2024, the drug Natasha C Edwin prescribed most often to Medicare patients was Acyclovir, with 113 prescriptions and refills. In total Natasha C Edwin wrote 833 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 113 | 145 | 34 | $2,156 |
| Hydroxyurea Generic | 59 | 108 | 16 | $1,016 |
| Dexamethasone Generic | 49 | 56 | 19 | $461 |
| Lenalidomide Generic | 41 | 41 | Under 11 | $301K |
| Revlimid Lenalidomide | 40 | 40 | 13 | $697K |
| Venclexta Venetoclax | 35 | 40 | 13 | $168K |
| Prochlorperazine Maleate Generic | 31 | 31 | 23 | $453 |
| Allopurinol Generic | 26 | 38 | 14 | $240 |
| Mirtazapine Generic | 24 | 28 | Under 11 | $612 |
| Eliquis Apixaban | 22 | 41 | Under 11 | $21K |
| Brukinsa Zanubrutinib | 19 | 19 | Under 11 | $279K |
| Oxycodone Hcl Generic | 17 | 17 | Under 11 | $95.88 |
| Ciprofloxacin Hcl Generic | 17 | 17 | Under 11 | $203 |
| Gabapentin Generic | 16 | 20 | Under 11 | $86.12 |
| Calquence Acalabrutinib Maleate | 16 | 16 | Under 11 | $213K |
Brand drugs: 206 claims; generic drugs: 627 claims; opioid claims: 32.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Natasha C Edwin $1,414 ($1,414 in general payments such as food, travel and fees) from 9 companies. The largest payer was Merck Sharp & Dohme LLC with $1,056.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.